Form 4: LMFA Director Gould Granted 104,760 Stock Options

Sentiment:

Insider Transaction Report


LM Funding America, Inc. Director and 10% owner Carollinn Gould was granted 104,760 stock options with an exercise price of $1.26.

Summary

  • Carollinn Gould, a Director and 10% owner of LM Funding America, Inc. (LMFA), was granted 104,760 stock options.
  • The options have an exercise price of $1.26 per share.
  • The grant date for these options was August 27, 2025.
  • Options were granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022.
  • Vesting occurs in two tranches: 50% on the 180th day after the grant date and the remaining 50% on the first anniversary of the grant date.
  • The options expire on August 27, 2035.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive signal for aligning interests and incentivizing long-term performance, reflecting standard corporate governance practices. No negative information is present.

Positives

  • Granting of stock options to a director aligns their interests with shareholders, incentivizing long-term performance.
  • The options were granted under an existing compensation plan, indicating a structured approach to director remuneration.

Future Outlook

The vesting schedule indicates a future commitment and incentive for the director over the next year from the grant date. The long expiration date (2035) provides a long-term incentive for the director to contribute to the company's success.

Industry Context

Granting stock options is a common practice in corporate compensation across various industries, including financial services, to align director and executive interests with shareholder value creation, particularly in companies seeking to retain key talent and incentivize long-term growth.

Comparison to Industry Standards

  • The grant of stock options to non-employee directors is a standard practice across many industries to incentivize long-term performance and align interests with shareholders.
  • The vesting schedule (50% at 180 days, 50% at 1 year) is a common structure designed to encourage continued service and commitment, comparable to practices at companies like JPMorgan Chase or Bank of America for their non-executive directors.
  • The exercise price of $1.26, likely the market price on the grant date, is typical for at-the-money option grants, similar to equity compensation structures seen in publicly traded financial technology firms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Plan UtilizationStock options granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022.08/27/2025Reinforces alignment of director incentives with long-term shareholder value through equity-based compensation.

Related Party Transactions

  • Grant of 104,760 stock options to Carollinn Gould, a Director and 10% owner, as part of her compensation package.

Stakeholder Impact

  • Shareholders: Potential for future dilution if options are exercised, but also increased alignment of the director's interests with long-term shareholder value creation.
  • Director (Carollinn Gould): Receives equity-based compensation, providing a direct financial incentive tied to the company's stock performance.

Next Steps

  • The options will vest in two tranches: 50% on the 180th day after August 27, 2025, and 50% on August 27, 2026.
  • Carollinn Gould may exercise these options at any time between their vesting dates and the expiration date of August 27, 2035.

Key Dates

DateDescription
11/18/2022Date the Non-Employee Director Compensation Plan was amended.
08/27/2025Grant date of 104,760 stock options to Carollinn Gould.
08/28/2025Signature date of the Form 4 filing.
08/27/2035Expiration date of the granted stock options.

Recommendation

hold

This Form 4 filing reports a routine grant of stock options to an existing director as part of their compensation plan. While it indicates alignment of interests, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard disclosure for insider equity compensation.

Keywords

LM Funding America, LMFA, Stock Options, Director Compensation, Insider Transaction, Carollinn Gould, Equity Grant, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.